# Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.

Study · id `cardio:ct-nct03733002` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03733002](<https://clinicaltrials.gov/study/NCT03733002>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03733002

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

## Technical summary

Registry record NCT03733002. Randomized; double masking; primary purpose treatment. Start 2018-12-01 (anticipated); primary completion 2019-12-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 100 participants (planned count; ClinicalTrials.gov record NCT03733002, source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)
- Planned start: 2018-12-01 (anticipated) (ClinicalTrials.gov record NCT03733002, source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)
- Primary completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT03733002, source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)
- Completion: 2019-12-30 (anticipated) (ClinicalTrials.gov record NCT03733002, source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT03733002, source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03733002-2018-11-07`, retrieved 2026-10-26)

## The registry's words

- Brief title: Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke.
- Acronym: AGNH2018
- Condition: Acute Ischemic Stroke
- Intervention (Drug): AngongNiuhuang pill
- Intervention (Drug): Placebo of AngongNiuhuang pill
- Intervention (Other): Standard treatment
- Lead sponsor: Peking Union Medical College Hospital
- Lead sponsor class: OTHER
- Collaborator: China-Japan Friendship Hospital
- Collaborator class: OTHER
- Collaborator: Cangzhou Central Hospital
- Collaborator class: OTHER
- Collaborator: The Second Hospital of Hebei Medical University
- Collaborator class: OTHER
- Collaborator: Affiliated Hospital of Chengde Medical University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Peking Union Medical College Hospital (`cardio:org-peking-union-medical-college-hospital`)
- Registry lists this organization as a collaborator: China-Japan Friendship Hospital (`cardio:org-china-japan-friendship-hospital`)
- Registry lists this organization as a collaborator: The Second Hospital of Hebei Medical University (`cardio:org-the-second-hospital-of-hebei-medical-university`)

## Provenance

Content hash: 7177ac31756eaf487dc97e6db60fe71d05b2ce3c3ef4cbe45f9d5b0cd01a635f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
